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Background
• The global push to achieve the 90-90-90 targets 
designed to end the HIV epidemic has called for the 
removing of policy barriers to prevention & treatment, 
and ensuring financial sustainability of HIV programs.
o This is critical for the wellbeing of HIV+ individuals.
• This is especially the case for women as:
o HIV in Sub-Saharan Africa and Kenya is a feminized 
epidemic.
o HIV+ women continue to desire children, become 
pregnant & give birth, making PMTCT critical.
o Women are more likely to experience negative 
health & economic shocks.
• Health insurance has been identified as a means to 
enhance & diversify financing and access to care. 
• In Kenya, the National Hospital Insurance Fund (NHIF) 
– the oldest SHI in Africa:
o Is important for PLWHA 
o Covers in-patient services, institutional delivery, and 
caesarian sections but not ART.
o However, enrollment in the NHIF even for 
specific high-risk groups such as HIV+ persons 
remains low!
Methods
• To determine the predictors of enrollment in NHIF we 
used different regression based methods.
• The methods included:
1. Univariate logistic regressions.
2. Multivariate logistic regressions.
3. Generalized Linear Models (GLM).
• The analysis was further stratified by HIV disease 
severity (based on CD4 cell count less than & above 
350)).
Results Discussion
1.Among HIV+ pregnant women, delivering at a health 
facility, being lost to follow-up during pregnancy and 
seeking care at an urban clinic, positively influences 
health insurance enrollment. 
2.However, being on HIV treatment is negatively 
associated with health insurance enrollment. The 
findings indicate that the health system in which HIV 
care is provided may influence health insurance 
enrollment. 
3.Additionally, HIV+ persons could potentially be less 
risk-averse thus limiting their enrollment in health 
insurance – potential for adverse selection exists.
4.If health insurance is to be adopted as a tool for 
comprehensively addressing and ending the HIV 
epidemic in low-resource settings, then further 
understanding of how HIV+ persons decide whether 
to enroll in health insurance is needed. 
5.Qualitative and Behavioral Economic research can 
help address the potential information 
asymmetries.
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Study Question:
What factors influence health insurance 
enrollment among HIV+ pregnant women?
Study Setting
• AMPATH – comprehensive HIV/AIDS 
programs in Western Kenya.
• Provides care to 150,000 plus HIV+ 
people.
Table 1: Demographic and Socio-Economic Characteristics of HIV+ Pregnant Women within AMPATH Electronic 
Medical Records 
Mean Values Study Sample 
 
Institutional Delivery Sample 
 NHIF Uninsured NHIF Uninsured 
Current Age 34.28 
(5.96) 
33.39 
(6.39) 
30.75 
(4.95) 
30.97 
(5.55) 
Age at Enrollment 29.51 
(5.61) 
29.03 
(5.86) 
26.91 
(4.47) 
27.42 
(5.02) 
Age- First Pregnant @ AMPATH 30.43 
(5.92) 
29.80 
(6.15) 
27.53 
(4.74) 
28.05 
(5.32) 
Ever Attended School (%) 97.82 
(16.29) 
92.17 
(0.35) 
98.87 
(10.6) 
99.30 
(8.29) 
Years of Schooling Completed 10.42 
(3.10) 
7.92 
(2.92) 
10.09 
(2.86) 
7.94 
(2.82) 
Number of Pregnancies at Enrollment in AMPATH 2.84 
(1.72) 
3.47 
(1.96) 
2.79 
(1.29) 
3.37 
(1.76) 
Number of Children 2.25 
(1.64) 
3.01 
(1.86) 
2.09 
(1.43) 
2.74 
(1.68) 
Enrolled Child at AMPATH (%) 66.42 
(47.89) 
68.06 
(47.68) 
76.4 
(42.70) 
79.45 
(40.43) 
Lost to Follow-up – During Pregnancy (%) 1.71 
(16.67) 
1.00 
(15.06) 
5.62 
(23.16) 
1.55 
(12.38) 
Currently on ARV Treatment 86.94 
(34.76) 
87.32 
(33.28) 
88.76 
(31.76) 
97.50 
(15.63) 
CD4 @ Enrollment 338.24 
(247.14) 
359.24 
(307.48) 
410.40 
(255.90) 
396.49 
(327.03) 
Travel Time (Hours) 1.97 
(0.99) 
2.05 
(0.98) 
1.89 
(0.94) 
2.00 
(0.95) 
# Days Pre ARV Initiation 286.46 
(475.11) 
271.15 
(429.65) 
262.07 
(354.62) 
227.13 
(354.62) 
# Days Post ARV Initiation 1828.68 
(876.28) 
1635.62 
(784.12) 
1535.34 
(952.05) 
1427.11 
(768.71) 
Urban Clinic (%) 70.06 
(47.59) 
44.80 
(50.0) 
69.70 
(46.23) 
42.06 
(49.39) 
 
Observations 
 
1997 
(15.86%) 
 
10596 
(84.14%) 
 
89 
(7.25%) 
 
1159 
(92.75%) 
 
Overall N 
 
12,593 
 
1,248 
 
Table 2: Predictors of Health Insurance Enrollment among HIV+ Pregnant Women – Confirmatory Approach 
 Bivariate Analysis Multivariate Analysis 
 Odds Ratio 95% CI P-Value Odds Ratio 95% CI P-Value 
Delivered at Health Institution 2.91 
(0.92) 
1.56-5.41 0.00 2.46 
(0.86) 
1.24-4.87 0.01 
Current Age 0.99 
(0.02) 
0.96-1.03 0.67 0.52 
(0.13) 
0.31-0.86 0.01 
Age at Enrollment 0.98 
(0.02) 
0.94-1.02 0.02 2.24 
(0.62) 
1.30-3.86 0.00 
Age at First Pregnancy at 
AMPATH 
0.98 
(0.02) 
0.95-1.02 0.32 0.86 
(0.08) 
0.72-1.02 0.09 
Ever Attended School 0.61 
(0.65) 
0.08-4.95 0.65 0.10 
(0.12) 
0.01-0.91 0.04 
Years of Schooling Completed 1.32 
(0.06) 
1.22-1.44 0.00 1.28 
(0.06) 
1.16-1.40 0.00 
# of Pregnancies at Enrollment 
in AMPATH 
0.80 
(0.05) 
0.71-0.91 0.00 0.91 
(0.14) 
0.68-1.22 0.54 
Number of Children 0.76 
(0.06) 
0.65-0.88 0.00 1.01 
(0.19) 
0.70-1.45 0.98 
Enrolled Child in AMPATH 0.84 
(0.22) 
0.50-1.40 0.50 0.78 
(0.24) 
0.43-1.41 0.40 
Lost to Follow-up – During 
Pregnancy 
3.77 
(1.95) 
1.37-10.41 0.01 9.90 
(5.37) 
3.42-28.67 0.00 
Currently on ARV Treatment 0.21 
(0.08) 
0.10-0.43 0.00 0.22 
(0.09) 
0.10-0.49 0.00 
CD4 at Enrollment 1.00 
(0.00) 
0.99-1.00 0.61 1.00 
(0.00) 
0.99-1.00 0.41 
# Days Pre ARV Initiation 1.00 
(0.00) 
0.99-1.00 0.33 1.00 
(0.00) 
1.00-1.00 0.00 
# Days Post ARV Initiation 1.00 
(0.00) 
0.99-1.00 0.29 1.00 
(0.00) 
1.00-1.00 0.00 
Travel Time (Hours) 0.89 
(0.11) 
0.69-1.12 0.29 1.02 
(0.14) 
0.79-1.33 0.87 
Enrolled in an Urban Clinic 3.16 
(0.75) 
1.98-5.05 0.00 2.50 
(0.63) 
1.53-4.12 0.00 
 
Table 3: Predictors of Health Insurance Enrollment among HIV+ Pregnant Women: Generalized Linear Models 
(GLM) 
 Multivariate Analysis 
 Odds Ratio 95% CI P-Value 
Delivered at Health Institution 2.46 
(0.84) 
1.26-4.80 0.01 
Current Age 0.52 
(0.13) 
0.32-0.85 0.01 
Age at Enrollment 2.24 
(0.63) 
1.29-3.89 0.00 
Age at First Pregnancy at AMPATH 0.86 
(0.08) 
0.71-1.04 0.12 
Ever Attended School 0.10 
(0.12) 
0.01-1.08 0.06 
Years of Schooling Completed 1.28 
(0.06) 
1.16-1.40 0.00 
# of Pregnancies at Enrollment in AMPATH 0.91 
(0.14) 
0.68-1.23 0.54 
Number of Children 1.01 
(0.17) 
0.73-1.39 0.98 
Enrolled Child in AMPATH 0.78 
(0.24) 
0.43-1.40 0.40 
Lost to Follow-up – During Pregnancy 9.90 
(6.87) 
2.54-38.59 0.00 
Currently on ARV Treatment 0.22 
(0.10) 
0.09-0.56 0.00 
CD4 at Enrollment 1.00 
(0.00) 
1.00-1.00 0.50 
# Days Pre ARV Initiation 1.00 
(0.00) 
1.00-1.00 0.00 
# Days Post ARV Initiation 1.00 
(0.00) 
1.00-1.00 0.00 
Travel Time (Hours) 1.00 
(0.13) 
0.79-1.32 0.87 
Enrolled in an Urban Clinic 2.50 
(0.65) 
1.51-4.15 0.00 
 
Table 4: Predictors of Health Insurance Enrollment among HIV+ Pregnant Women: Stratified by HIV Disease Severity 
 CD4 ≤ 350 CD4 > 350 
 Odds Ratio 95% CI P-Value Odds Ratio 95% CI P-Value 
Delivered at Health Institution 3.69 
(2.19) 
1.15-11.82 0.03 1.82 
(0.83) 
0.75-4.45 0.19 
Current Age 0.49 
(0.20) 
0.22-1.08 0.08 0.50 
(0.18) 
0.25-1.02 0.06 
Age at Enrollment 2.16 
(0.91) 
0.94-4.94 0.07 2.92 
(1.32) 
1.20-7.08 0.02 
Age at First Pregnancy at 
AMPATH 
0.92 
(0.10) 
0.75-1.13 0.41 0.70 
(0.14) 
0.48-1.01 0.06 
Ever Attended School 1.00   0.02 
(0.03) 
0.00-0.33 0.01 
Years of Schooling Completed 1.10 
(0.07) 
0.97-1.25 0.13 1.48 
(0.12) 
1.28-1.71 0.00 
# of Pregnancies at Enrollment 
in AMPATH 
1.00 
(0.23) 
0.65-1.53 0.98 0.83 
(0.19) 
0.53-1.29 0.41 
Number of Children 1.03 
(0.27) 
0.62-1.73 0.91 1.02 
(0.30) 
0.57-1.82 0.96 
Enrolled Child in AMPATH 0.65 
(0.30) 
0.26-1.62 0.36 0.91 
(0.42) 
0.37-2.23 0.83 
Lost to Follow-up – During 
Pregnancy 
3.06 
(2.50) 
0.61-15.18 0.17 17.42 
(14.22) 
3.52-86.29 0.00 
Currently on ARV Treatment 0.03 
(0.04) 
0.00-0.32 0.00 0.48 
(0.26) 
0.17-1.38 0.18 
# Days Pre ARV Initiation 1.00 
(0.00) 
0.99-1.00 0.12 1.00 
(0.00) 
1.00-1.00 0.01 
# Days Post ARV Initiation 1.00 
(0.00) 
1.00-1.01 0.03 1.00 
(0.00) 
1.00-1.01 0.02 
Travel Time (Hours) 1.24 
(0.28) 
0.80-1.93 0.33 0.84 
(0.14) 
0.60-1.17 0.30 
Enrolled in an Urban Clinic 5.71 
(2.54) 
2.40-13.6 0.00 1.19 
(0.40) 
0.61-2.31 0.62 
N (Sample Size) 640   607   
 
